Cybrdi, Inc. Stock

CYDI

US23254K1007

Biotechnology & Medical Research

Delayed OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-50.91%

31/10/17	Xi’an Alena Biotechnology Co., Ltd completed the acquisition of 80% stake in Shaanxi Chaoying Bio-Technology Co., Ltd. from Cybrdi, Inc..	CI
19/07/17	Xi’an Alena Biotechnology Co., Ltd entered into a share transfer agreement to acquire 80% stake in Shaanxi Chaoying Bio-Technology Co., Ltd. from Cybrdi, Inc. for CNY 25.6 million.	CI

Cybrdi Inc is a united states-based company, which operates as a holding company. The Company's subsidiaries include Chaoying Biotech which is engaged in biotechnology manufacturing, and research and development company. Through Chaoying Biotech, Cybrdi controls SD Chaoying, a Cultural and Entertainment company. Its key product is tissue chips, intended to provide high-throughput molecular profiling and parallel analysis of biological and molecular characteristics for hundreds of pathologically controlled tissue specimens. The Companyâ€™s Tissue Microarrays (TMAs) segment offers a variety of tissue array products and services on the commercial market. The Technical Services segment provides in-house technical services platform to perform customized research according to customer specifications. The Culture, Entertainment, and Real Estate Business segment is developing a Culture and Entertainment Square in Changle City of Shandong Province.

Employees

Sector

Biotechnology & Medical Research

More about the company

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

Stock Market
Stocks
CYDI Stock

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	2.52M 2.19M 2.05M 1.87M 3.51M 241M 3.57M 24.11M 9.42M 121M 9.48M 9.27M 402M	P/E 2012	-1.82x	P/E 2013	-2.85x
Enterprise Value	6.51M 5.64M 5.29M 4.82M 9.07M 621M 9.21M 62.2M 24.31M 311M 24.46M 23.93M 1.04B	EV / Sales 2012	3.25x	EV / Sales 2013	9.67x
Free-Float	29.19%	Yield 2012 *	-	Yield 2013	-

Manager	Title	Age	Since
Yan Biao Bai CEO	Chief Executive Officer	63	01/01/2003
Yong Hong Ren COO	Chief Operating Officer	-	19/08/2011

Director	Title	Age	Since
Yan Biao Bai CHM	Chairman	63	01/01/2003
Yong Hong Ren BRD	Director/Board Member	-	19/08/2011

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CYBRDI, INC.	-.--%	-.--%	-	-	325K
LONZA GROUP AG	-1.60%	+0.86%	+3.70%	+14.57%	49.54B
REVOLUTION MEDICINES, INC.	-0.37%	+3.51%	+479.21%	+580.77%	44.06B
BEONE MEDICINES AG	-0.55%	+9.19%	+24.13%	+75.19%	40.85B
IQVIA HOLDINGS INC.	-0.44%	+3.03%	+30.82%	+10.49%	40.14B
CELLTRION, INC.	-4.04%	+8.72%	+22.60%	+48.00%	34.17B
MEDPACE HOLDINGS, INC.	-1.11%	+2.27%	+30.88%	+126.31%	16.9B
ASCENDIS PHARMA A/S	+0.19%	+4.42%	-	-	16.78B
EUROFINS SCIENTIFIC SE	-0.43%	-0.11%	+4.22%	+20.71%	14B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.64%	+10.24%	+88.16%	+32.51%	13.46B
Average	-0.66%	+6.27%	+85.47%	+113.57%	26.99B
Weighted average by Cap.	-0.99%	+6.51%	+102.95%	+135.52%

	2012	2013
Net sales	783K 679K 636K 580K 1.09M 74.7M 1.11M 7.48M 2.92M 37.4M 2.94M 2.88M 125M	574K 498K 466K 425K 799K 54.77M 812K 5.48M 2.14M 27.43M 2.16M 2.11M 91.45M
Net income	-530K -459K -430K -392K -737K -50.53M -749K -5.06M -1.98M -25.3M -1.99M -1.95M -84.37M	-548K -475K -445K -406K -763K -52.3M -775K -5.24M -2.05M -26.19M -2.06M -2.01M -87.33M
Net Debt	1.58M 1.37M 1.29M 1.17M 2.2M 151M 2.24M 15.12M 5.91M 75.61M 5.94M 5.81M 252M	3.99M 3.46M 3.24M 2.95M 5.55M 381M 5.64M 38.09M 14.89M 191M 14.98M 14.65M 635M

Cybrdi, Inc. Stock

Stocks

CYDI

US23254K1007

Biotechnology & Medical Research

Valuation: Cybrdi, Inc.

Latest news : Cybrdi, Inc.

Managers and Directors: Cybrdi, Inc.

Other Biotechnology & Medical Research

Financials

Company Profile